LONDON--(BUSINESS WIRE)--MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced the appointment of David Blakey Ph.D. as Chief Scientific Officer. Dr. Blakey will lead the Company’s research and development activities.
“David brings to MiNA a depth of scientific expertise that will be critical in advancing our pipeline of innovative RNA-based therapies,” said Robert Habib, CEO of MiNA Therapeutics.
Help employers find you! Check out all the jobs and post your resume.
“David brings to MiNA a depth of scientific expertise that will be critical in advancing our pipeline of innovative RNA-based therapies,” said Robert Habib, CEO of MiNA Therapeutics.
Help employers find you! Check out all the jobs and post your resume.
